3Fitzpatrick TB, et al. Dermatology in general medicine .4th ed . New York : McGraw-Hill, 1993.601-605.
4Acland KM, Darvay A, Griffin C, et al. Staphylococcal scalded skin syndrome in an adult associated with methicillin-resistant Staphylococcus aureus. Br J Dermatol, 1999,140(3) :518-520.
5Rago JV, Vath GM, Tripp TJ, et al. Staphylococcal exfoliative toxins cleave alpha- and beta-melanocyte-stimulating hormones. Infect Immun,2000,68(4) :2366-2368.
6Vath GM, Earhart CA, Monie DD, et al. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. Biochemistry, 1999,38(32): 10239-10246.
7Lina G, Gillet Y, Vandenesch F, et al. Toxin involvement in staphylococcal scalded skin syndrome. Clin Infect Dis, 1997 , 25 ( 6 ): 1369-1373.
8Ladhani S, Joannou CL, Lochrie DP, et al. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scaldedskin syndrome. Clin Microbiol Rev, 1999 , 12(2) :224-242.
9Rago JV, Vath GM, Bohach GA, et al. Mutational analysis of the superantigen staphylococcal exfoliative toxin A (ETA). J Immunol, 2000, 164(4) :2207-2213.
10Ninomiya J, Ito Y, Takiuchi I. Purification of protease from a mixture of exfoliative toxin and newborn-mouse epidermis. Infect Immtm, 2000, 68(9) :5044-5049.
4Yamasaki O, Yamaguchi T, Sugai M, et al. Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins[J]. J Clin Microbiol, 2005, 43(4): 1890-1893.
